169 results on '"Leslie, Connull"'
Search Results
2. Real-world prevalence of PD-L1 expression in non-small cell lung cancer: an Australia-wide multi-centre retrospective observational study
3. Adequacy of cytology and small biopsy samples obtained with rapid onsite evaluation (ROSE) for predictive biomarker testing in non-small cell lung cancer
4. A surgically optimized intraoperative poly(I:C)-releasing hydrogel prevents cancer recurrence
5. Palisading Adenocarcinoma: A Morphologically Unique Salivary Gland Tumor With a Neuroendocrine-like Appearance and a Predilection for the Sublingual Glands of Women
6. The Ring Study: an international comparison of PD-L1 diagnostic assays and their interpretation in non-small cell lung cancer, head and neck squamous cell cancer and urothelial cancer
7. Follicular Lymphoma: Epidemiology, Pathogenesis and Initiating Events
8. Molecular Testing in Colorectal Carcinoma
9. Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in
10. Author Correction: Low-coverage whole-genome sequencing of extracellular vesicle-associated DNA in patients with metastatic cancer
11. Low-coverage whole-genome sequencing of extracellular vesicle-associated DNA in patients with metastatic cancer
12. Detection of Low-level EGFR c.2369 C > T (p.Thr790Met) Resistance Mutation in Pre-treatment Non-small Cell Lung Carcinomas Harboring Activating EGFR Mutations and Correlation with Clinical Outcomes
13. Programmed death ligand-1 expression in non-small cell lung cancer in a Western Australian population and correlation with clinicopathologic features
14. Patterns of p53 immunoreactivity in non-neoplastic and neoplastic Barrett's mucosa of the oesophagus: in-depth evaluation in endoscopic mucosal resections
15. Follicular Lymphoma: Epidemiology, Pathogenesis and Initiating Events
16. A comparative study of extracellular vesicle-associated and cell-free DNA and RNA for HPV detection in oropharyngeal squamous cell carcinoma
17. Molecular Testing in Colorectal Carcinoma
18. 'Table S1' from Intra- and Interobserver Reproducibility Assessment of PD-L1 Biomarker in Non–Small Cell Lung Cancer
19. Cervical carcinomas with a micropapillary component: a clinicopathological study of eight cases
20. Palisading Adenocarcinoma
21. Clinical and therapeutic implications of BRAF mutation heterogeneity in metastatic melanoma
22. Improving outcomes for patients with lymphoma: Design and development of the Australian Lymphoma and Related Diseases Registry
23. PPARα and PPARγ activation is associated with pleural mesothelioma invasion but therapeutic inhibition is ineffective
24. T-lymphoblastic proliferation and florid multifocal follicular dendritic cell proliferation occurring in hyaline-vascular Castleman disease in a patient with a possible familial predisposition
25. FOXP3+ T regulatory lymphocytes in primary melanoma are associated with BRAF mutation but not with response to BRAF inhibitor
26. BRAF p.Val600Glu (V600E) mutation detection in thyroid fine needle aspiration cell block samples: a feasibility study
27. 34. BRAF V600E MUTATION DETECTION IN CELL BLOCKS OF THYROID FINE NEEDLE ASPIRATION CYTOLOGY SAMPLES
28. 33. ASSOCIATION OF FOXP3+ TUMOUR INFILTRATING LYMPHOCYTE DENSITY IN PRIMARY MELANOMA WITH BRAF AND NRAS MUTATION STATUS
29. More than just counting eosinophils: proximal oesophageal involvement and subepithelial sclerosis are major diagnostic criteria for eosinophilic oesophagitis
30. Anaplastic large-cell lymphoma associated with breast implants: A unique entity within the spectrum of peri-implant effusions
31. Detection of EGFR mutational profile by direct dideoxy sequencing in cytology and non-cytology biopsy samples
32. 30. GENOME-WIDE MICRO-RNA PROFILING DISTINGUISHES DIFFUSE LARGE B-CELL LYMPHOMA OF THE CENTRAL NERVOUS SYSTEM FROM SYSTEMIC DLBCL
33. Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in
34. Characterization of the immune profile of oral tongue squamous cell carcinomas with advancing disease
35. Final Results of the Dream Trial: A Phase 2 Trial of Durvalumab with First-Line Chemotherapy in Mesothelioma with a Safety Run-In
36. Cartilaginous differentiation in a giant congenital melanocytic naevus
37. Indolent relapse after initial aggressive B-cell lymphoma: a single institution experience in the rituximab era.
38. Atypical Features Resembling Poorly Differentiated Thyroid Carcinoma Presenting Entirely within a Follicular Adenoma
39. Peripheral T-Cell Lymphoma Arising in Patients With Chronic Lymphocytic Leukemia
40. Sensitization to immune checkpoint blockade through activation of a STAT1/NK axis in the tumor microenvironment
41. Low-coverage whole genome sequencing of FFPE-derived-DNA and extracellular vesicle-associated DNA in patients with metastatic cancer.
42. Peripheral T-Cell Lymphoma Arising in Patients With Chronic Lymphocytic Leukemia.
43. An unusual case of hepatosplenic T cell lymphoma in a 59-year-old woman
44. A national pathology review committee for the lymphoma and related diseases registry
45. Cervical carcinomas with a micropapillary component: a clinicopathological study of eight cases
46. The Diagnostic, Prognostic, and Therapeutic Utility of Molecular Testing in a Patient with Waldenstrom’s Macroglobulinemia
47. Intra- and Interobserver Reproducibility Assessment of PD-L1 Biomarker in Non–Small Cell Lung Cancer
48. Clinical and therapeutic implications ofBRAFmutation heterogeneity in metastatic melanoma
49. P2.01-047 Intra- and Inter-Observer Reproducibility Study of PD-L1 Biomarker in Non-Small Cell Lung Cancer (NSCLC) - The DREAM STUDY
50. Is the Detection of Endometrial Nerve Fibers Useful in the Diagnosis of Endometriosis?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.